Granted Patent
B2
US 8,609,679 · App. 13/671,112 · Granted Dec 17, 2013
2,4-diaminopyrimidines useful as kinase inhibitors
Inventors:
Juswinder Singh (Ashland, MA); Russell C. Petter (Stow, MA); Richland Wayne Tester (Marlborough, MA); Arthur F. Kluge (Lincoln, MA); Hormoz Mazdiyasni (Marlborough, MA); William Frederick Westlin, III (Boxborough, MA); Deqiang Niu (Lexington, MA); Lixin Qiao (Tewksbury, MA)
Assignee:
Celgene Avilomics Research, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides 2,4-diaminopyrimidine compounds useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.
Claims (5)
1. A compound of the following structure:
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising the compound according to claim 1 , and a pharmaceutically acceptable carrier, adjuvant, or vehicle.
3. The pharmaceutical composition according to claim 2 , wherein said composition is formulated for parenteral administration.
4. The pharmaceutical composition according to claim 2 , wherein said compound is formulated for oral administration.
Assignments (3)
NUNC PRO TUNC ASSIGNMENT
Recorded May 3, 2023
From: CELGENE CAR LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 063526/0959 →
MERGER AND CHANGE OF NAME
Recorded Feb 16, 2017
From: CELGENE AVILOMICS RESEARCH, INC.; CELGENE CAR LLC
To: CELGENE CAR LLC
Reel/Frame 041738/0041 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 1, 2013
From: SINGH, JUSWINDER; PETTER, RUSSELL C.; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.; MAZDIYASNI, HORMOZ; WESTLIN, WILLIAM FREDERICK, III; NIU, DEQIANG; QIAO, LIXIN
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029740/0109 →
Continuity (6)
Provisional Application
61076450
· Jun 27, 2008
Provisional Application
61148388
· Jan 29, 2009
Provisional Application
61170874
· Apr 20, 2009